EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

A comprehensive review of m 6 A research in cervical cancer

Jing Hu, Shizhi Wang iD, Xiuting Li

Epigenomics · 18.05.2024 · 16 (10) · 753-773

DOI: 10.2217/epi-2024-0002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Epigenomics, online erschienen am 19.04.2024. Verfasst von Jing Hu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Environmental Medicine & Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Adenosine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Opening Foundation of Jiangsu Provincial Health Development Research Center, Natural Science Foundation for Colleges and Universities of Jiangsu Province, Major Project of Jiangsu Health Vocational College.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer (CC) remains one of the most common malignancies among women worldwide, posing a serious threat to women's health. N6-methyladenosine (m6A) modification, as the most abundant type of RNA methylation modification, and has been found to play a crucial role in various cancers. Current research suggests a close association between RNA m6A modification and the occurrence and progression of CC, encompassing disruptions in m6A levels and its regulatory machinery. This review summarizes the current status of m6A modification research in CC, explores the mechanisms underlying m6A levels and regulators (methyltransferases, demethylases, reader proteins) in CC and examines the application of small-molecule inhibitors of m6A regulators in disease treatment. The findings provide new insights into the future treatment of CC. The m6A modification participates in regulating the proliferation, migration, invasion, cell cycle, apoptosis, drug resistance and sensitivity to chemotherapy in cervical cancer cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsAdenosineHumansFemaleMethyltransferases

Stichwörter der Autor:innen

cervical cancerm6A modificationmechanismsmoleculesregulatorstreatment

Substanzen

AdenosineN-methyladenosineMethyltransferases

Autor:innen und Institutionen

  • Key Laboratory of Environmental Medicine & Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
  • Department of Public Health, Jiangsu Health Vocational College, Nanjing, 210000, China.

ORCID-Profile: Shizhi Wang

Förderung

  • Opening Foundation of Jiangsu Provincial Health Development Research Center
  • Natural Science Foundation for Colleges and Universities of Jiangsu Province
  • Major Project of Jiangsu Health Vocational College
  • Scientific Research Project of Jiangsu Provincial Health Commission
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Hu, J., Wang, S., & Li, X. (2024). A comprehensive review of m 6 A research in cervical cancer. Epigenomics, 16(10), 753-773. https://doi.org/10.2217/epi-2024-0002

Vancouver

Hu J, Wang S, Li X. A comprehensive review of m 6 A research in cervical cancer. Epigenomics. 2024;16(10):753-773. doi:10.2217/epi-2024-0002

BibTeX
@article{Hu2024,
  author = {Hu, Jing and Wang, Shizhi and Li, Xiuting},
  title = {A comprehensive review of m 6 A research in cervical cancer},
  journal = {Epigenomics},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {753--773},
  doi = {10.2217/epi-2024-0002}
}
Kostenlos starten →